Revelation Biosciences Inc REVB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/10/24 EDT
2.06quote price arrow down-0.14 (-6.36%)
Volume
37,439
52 week range
1.78 - 39.00
Loading...
  • Open2.17
  • Day High2.23
  • Day Low2.01
  • Prev Close2.20
  • 52 Week High39.00
  • 52 Week High Date05/22/23
  • 52 Week Low1.78
  • 52 Week Low Date04/15/24

Key Stats

  • Market Cap3.364M
  • Shares Out1.63M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.21
  • YTD % Change-86.29

KEY STATS

  • Open2.17
  • Day High2.23
  • Day Low2.01
  • Prev Close2.20
  • 52 Week High39.00
  • 52 Week High Date05/22/23
  • 52 Week Low1.78
  • 52 Week Low Date04/15/24
  • Market Cap3.364M
  • Shares Out1.63M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta0.21
  • YTD % Change-86.29

RATIOS/PROFITABILITY

  • EPS (TTM)29.29
  • P/E (TTM)0.07
  • Fwd P/E (NTM)-0.10
  • EBITDA (TTM)-8.632M
  • ROE (TTM)-3.12%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Revelation Biosciences Inc

 

Content From Our Affiliates

Profile

MORE
Revelation Biosciences, Inc. is a clinical-stage life sciences company engaged in the development of innate immune system therapeutics and diagnostics. Its therapeutic candidates are based on its Gemini formulation of active ingredient phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA) that is known to stimulate Toll-like receptor 4 (TLR-4). Its product candidates include Gemini-SSI, which is being developed for the prevention...
George Tidmarsh M.D., Ph.D.
Independent Chairman of the Board
James Rolke
Chief Executive Officer, Co-Founder, Director
Chester Zygmont III
Chief Financial Officer
Address
4660 Lajolla Village Drive, Suite 100
San Diego, CA
92122
United States

Top Peers

SYMBOLLASTCHG%CHG
SLRX
Salarius Pharmaceuticals Inc
0.4875-0.0199-3.922%
ELOX
Eloxx Pharmaceuticals Inc
0.9161+0.1028+12.6357%
GLMD
Galmed Pharmaceuticals Ltd
0.394-0.021-5.0602%
DRMA
Dermata Therapeutics Inc
0.3587+0.0351+10.8467%
FWBI
First Wave BioPharma Inc
2.85+0.03+1.06%